Autoimmune hemolytic anemia associated with multiple myeloma: a rare case report
Abstract
Background. Autoimmune hemolytic anemia (AIHA) is characterized by autoantibodies binding to red blood cell antigens, leading to hemolysis through complement activation and the reticuloendothelial system. It is commonly associated with B-cell lymphoproliferative disorders, while its occurrence in multiple myeloma (MM) is rare. AIHA may create diagnostic challenges because anemia in MM is usually attributed to bone marrow infiltration or chronic disease rather than immune-mediated hemolysis. Case report. A 74-year-old man presented with weakness and decreased appetite. Laboratory findings revealed anemia with anisopoikilocytosis, leukopenia, and thrombocytopenia. Peripheral blood smear demonstrated red blood cell agglutination, spherocytes, and rouleaux formation, accompanied by increased LDH, indirect bilirubin, and reticulocytosis, which were consistent with active hemolysis. The monospecific direct antiglobulin test was positive for IgG, confirming warm-type AIHA. Bone marrow examination showed 46% plasma cell infiltration with erythroid hyperplasia, serum protein electrophoresis revealed monoclonal gammopathy, and hypercalcemia was also present, establishing the diagnosis of MM with secondary AIHA. The patient received high-dose intravenous methylprednisolone followed by a combination of bortezomib and dexamethasone chemotherapy, resulting in progressive clinical and laboratory improvement. Conclusions. AIHA secondary to MM is rare but clinically significant. AIHA should be considered in MM patients presenting with anemia accompanied by laboratory evidence of hemolysis, and combined immunosuppressive and anti-myeloma therapy led to a favorable outcome in our patient.